Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | EPB41L1 |
| Upstream (Parents) |
|---|
| (<<) S100A11 → EPB41L1 |
| (<<) TES → EPB41L1 |
| (<<) DLGAP4 → EPB41L1 |
| (<<) GALNT12 → EPB41L1 |
| (<<) BDKRB2 → EPB41L1 |
| Downstream (Children) |
|---|
| EPB41L1 → CHAF1A (>>) |
| EPB41L1 → CDC42BPA (>>) |
| EPB41L1 → INPP4B (>>) |
| EPB41L1 → TRIM24 (>>) |
| EPB41L1 → AFAP1 (>>) |
| EPB41L1 → SH3GLB2 (>>) |
| EPB41L1 → SEMA5A (>>) |
| EPB41L1 → GOLM1 (>>) |
| EPB41L1 → OLFM4 (>>) |
| EPB41L1 → PCP4 (>>) |
| EPB41L1 → HOXD1 (>>) |
| EPB41L1 → TNK2 (>>) |
| EPB41L1 → IGLV4-60 (>>) |
| EPB41L1 → CHRM3 (>>) |
| EPB41L1 → COL2A1 (>>) |
| EPB41L1 → CXCR5 (>>) |
| EPB41L1 → GOLGA6L4///PML (>>) |
